AAAAAA

   
Results: 1-10 |
Results: 10
Effect of OROS (R) controlled-release delivery on the pharmacokinetics andpharmacodynamics of oxybutynin chloride
Authors: Sathyan, G Chancellor, MB Gupta, SK
Citation: G. Sathyan et al., Effect of OROS (R) controlled-release delivery on the pharmacokinetics andpharmacodynamics of oxybutynin chloride, BR J CL PH, 52(4), 2001, pp. 409-417
A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate
Authors: Chancellor, MB Appell, RA Sathyan, G Gupta, SK
Citation: Mb. Chancellor et al., A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate, CLIN THER, 23(5), 2001, pp. 753-760
Lack of effect of food on the pharmacokinetics of an extended-release oxybutynin formulation
Authors: Sathyan, G Hu, WT Gupta, SK
Citation: G. Sathyan et al., Lack of effect of food on the pharmacokinetics of an extended-release oxybutynin formulation, J CLIN PHAR, 41(2), 2001, pp. 187-192
A semiparametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutynin
Authors: Pitsiu, M Sathyan, G Gupta, S Verotta, D
Citation: M. Pitsiu et al., A semiparametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutynin, J PHARM SCI, 90(6), 2001, pp. 702-712
Effect of dosing time on the total intestinal transit time of non-disintegrating systems
Authors: Sathyan, G Hwang, S Gupta, SK
Citation: G. Sathyan et al., Effect of dosing time on the total intestinal transit time of non-disintegrating systems, INT J PHARM, 204(1-2), 2000, pp. 47-51
Modeling of circadian testosterone in healthy men and hypogonadal men
Authors: Gupta, SK Lindemulder, EA Sathyan, G
Citation: Sk. Gupta et al., Modeling of circadian testosterone in healthy men and hypogonadal men, J CLIN PHAR, 40(7), 2000, pp. 731-738
Effects of nandrolone decanoate therapy in borderline hypogonadal men withHIV-associated weight loss
Authors: Strawford, A Barbieri, T Neese, R Van Loan, M Christiansen, M Hoh, R Sathyan, G Skowronski, R King, J Hellerstein, M
Citation: A. Strawford et al., Effects of nandrolone decanoate therapy in borderline hypogonadal men withHIV-associated weight loss, J ACQ IMM D, 20(2), 1999, pp. 137-146
Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin
Authors: Gupta, SK Sathyan, G
Citation: Sk. Gupta et G. Sathyan, Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin, J CLIN PHAR, 39(3), 1999, pp. 289-296
Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system
Authors: Gupta, SK Sathyan, G Phipps, B Klausner, M Southam, M
Citation: Sk. Gupta et al., Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system, J PHARM SCI, 88(8), 1999, pp. 835-841
Quantitative characterization of therapeutic index: Application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships
Authors: Gupta, SK Sathyan, G Lindemulder, EA Ho, PL Sheiner, LB Aarons, L
Citation: Sk. Gupta et al., Quantitative characterization of therapeutic index: Application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships, CLIN PHARM, 65(6), 1999, pp. 672-684
Risultati: 1-10 |